Clincosm LogoSign in Get a demo

solid tumor malignancy

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Participants Previously Treated With Century Therapeutics

Not yet recruiting
  • Hematological Malignancy
  • Solid Tumor Malignancy
  • No Intervention
  • (no location specified)
Mar 3, 2023

Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

Recruiting
  • Solid Tumor Malignancy
  • +4 more
  • mRNA-1273
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 14, 2023

Solid Tumor Malignancy Trial in Worldwide (Pemigatinib)

Terminated
  • Solid Tumor Malignancy
  • Goodyear, Arizona
  • +89 more
Jun 14, 2022

COVID-19 Vaccines in Cancer, Transplant or Cellular Therapy

Recruiting
  • Cancer
  • +7 more
    • Memphis, Tennessee
    • +2 more
    Mar 2, 2022

    Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)

    Withdrawn
    • Solid Tumor Malignancy
    • Hackensack, New Jersey
      John Theurer Cancer Center at HackensackUMC
    Dec 14, 2021

    Solid Tumor Malignancy, Lymphoid Malignancy (Lymphoma and CLL), Leukemia Trial run by the (SNX-5422 Mesylate Hsp90 inhibitor)

    Completed
    • Solid Tumor Malignancy
    • +3 more
    • SNX-5422 Mesylate Hsp90 inhibitor
    • Bethesda, Maryland
      Pfizer Investigational Site
    May 15, 2012